Form 8-K - Current report:
SEC Accession No. 0001437749-25-030125
Filing Date
2025-09-30
Accepted
2025-09-30 16:43:20
Documents
22
Period of Report
2025-09-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K govx20250930_8k.htm   iXBRL 8-K 36359
2 EXHIBIT 4.1 ex_865347.htm EX-4.1 114812
3 EXHIBIT 5.1 ex_865348.htm EX-5.1 10214
4 EXHIBIT 10.1 ex_865349.htm EX-10.1 151029
5 EXHIBIT 10.2 ex_865350.htm EX-10.2 229338
6 EXHIBIT 99.1 ex_865351.htm EX-99.1 12044
11 ex_865348img001.jpg GRAPHIC 2788
12 logosm.jpg GRAPHIC 12780
13 wbdlogo01.jpg GRAPHIC 24822
14 wbdweb01.jpg GRAPHIC 11789
  Complete submission text file 0001437749-25-030125.txt   892894

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION SCHEMA govx-20250930.xsd EX-101.SCH 3579
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE govx-20250930_def.xml EX-101.DEF 11424
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE govx-20250930_lab.xml EX-101.LAB 15310
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE govx-20250930_pre.xml EX-101.PRE 11584
24 EXTRACTED XBRL INSTANCE DOCUMENT govx20250930_8k_htm.xml XML 2840
Mailing Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080
Business Address 1900 LAKE PARK DRIVE SUITE 380 SMYRNA GA 30080 678-384-7220
GeoVax Labs, Inc. (Filer) CIK: 0000832489 (see all company filings)

EIN.: 870455038 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39563 | Film No.: 251361123
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)